GFAP and Alzheimer disease: To our knowledge, no study to date has jointly investigated p‐tau217, NfL, GFAP, and biomarker profiles, with a specific focus on AD, bvFTD, PPD, in younger people, where differential diagnoses, diagnostic uncertainty, misdiagnosis, and delay are greater.1, 33, 34, 35